A Clinical Study on the Efficacy and Safety of Fasudil Hydrochloride Combined With Immunotherapy in the Treatment of Metastatic Castration-resistant Prostate Cancer

NCT07250542 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Fasudil hydrochloride combined with immunotherapy

Sponsor

baotai Liang